Cellectar Biosciences, Inc.CLRBNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank64
3Y CAGR-12.7%
5Y CAGR-25.4%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-12.7%/yr
vs +10.6%/yr prior
5Y CAGR
-25.4%/yr
Recent acceleration
Acceleration
-23.4pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $13.20M | -43.3% |
| 2024 | $23.29M | +143.5% |
| 2023 | $9.56M | -51.9% |
| 2022 | $19.87M | -44.4% |
| 2021 | $35.70M | -37.5% |
| 2020 | $57.17M | +438.5% |
| 2019 | $10.61M | -19.9% |
| 2018 | $13.26M | +32.5% |
| 2017 | $10.01M | -12.6% |
| 2016 | $11.44M | - |